Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 18;13(2):395. doi: 10.3390/biom13020395

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

FKBPL plasma protein concentrations in patients with HFpEF. Patients were divided into subgroups based on HFpEF symptoms: HCM (n = 15), chronic HFpEF (n = 9) and acute decompensated HFpEF (n = 9). (A) FKBPL plasma concentration of combined HFpEF subgroups compared to controls (n = 40). (B) FKBPL plasma concentration within HFpEF subgroups, compared to controls. Results expressed as Mean ± SD; One-way ANOVA with Tukey’s post-hoc; * p < 0.05, ** p < 0.005. HCM—hypertrophic cardiomyopathy; HFpEF—chronic heart failure with preserved ejection fraction; AD-HFpEF—acute decompensated HFpEF.